Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT01561222

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Taixing People's Hospital (from the registry)
Registry
  • NCT NCT01561222
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01561222. Randomized; double masking; primary purpose prevention. Start 2015-07 (registry gives no type); primary completion 2016-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
Condition
Chronic Kidney Disease Stage 1
Condition
Chronic Kidney Disease Stage 2
Intervention (Drug)
Calcitriol
Intervention (Drug)
placebo
Lead sponsor
Taixing People's Hospital (class: other)

Record details

Record id
cardio:ct-nct01561222
Content hash
b75e56ff586f4da7f51f0b1077cfbb8fa38e90da846524e7223a1a6384a8c6f5